NorthCoast Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$364K Buy
5,212
+123
+2% +$8.64K 0.01% 372
2021
Q2
$351K Sell
5,089
-154
-3% -$10.3K 0.01% 368
2021
Q1
$339K Sell
5,243
-9,097
-63% -$587K 0.01% 347
2020
Q4
$837K Buy
14,340
+215
+2% +$13K 0.04% 219
2020
Q3
$895K Buy
14,125
+9,434
+201% +$654K 0.05% 194
2020
Q2
$361K Buy
4,691
+7
+0.1% +$536 0.02% 259
2020
Q1
$350K Buy
+4,684
New +$324K 0.02% 254
2017
Q1
Sell
-320,403
Closed -$22.9M 184
2016
Q4
$22.9M Sell
320,403
-96,542
-23% -$7.18M 2.3% 12
2016
Q3
$33M Sell
416,945
-149,780
-26% -$12.2M 2.69% 13
2016
Q2
$47.3M Sell
566,725
-96,398
-15% -$8.55M 3.23% 4
2016
Q1
$60.9M Buy
663,123
+75,376
+13% +$6.8M 5.17% 3
2015
Q4
$59.5M Sell
587,747
-36,222
-6% -$3.77M 3.86% 4
2015
Q3
$61.3M Sell
623,969
-13,163
-2% -$1.46M 3.34% 6
2015
Q2
$74.6M Sell
637,132
-153,186
-19% -$16.7M 3.57% 5
2015
Q1
$77.6M Buy
790,318
+53,102
+7% +$5.39M 3.63% 4
2014
Q4
$69.5M Buy
737,216
+155,647
+27% +$16.1M 3.42% 7
2014
Q3
$61.9M Sell
581,569
-159,934
-22% -$15.7M 3.05% 8
2014
Q2
$61.5M Buy
741,503
+21,369
+3% +$1.66M 3.57% 2
2014
Q1
$51M Buy
+720,134
New +$56.5M 3.33% 10
2013
Q3
Sell
-14,225
Closed -$729K 180
2013
Q2
$729K Buy
+14,225
New +$741K 0.06% 116

Other funds holding GILD

NorthCoast Asset Management's GILD Position: Q3 2021 in Review

NorthCoast Asset Management increased its Gilead Sciences (GILD) stake by 2.4% in Q3 2021, buying an estimated $8.64K and bringing the position to 5,212 shares worth $364K. The position accounts for 0.01% of the portfolio, ranked #372.

NorthCoast Asset Management first reported a position in GILD in Q2 2013 and has held it in 20 quarters since. The position peaked at $77.6M in Q1 2015. 1,564 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

  • NorthCoast Asset Management held 5,212 shares of Gilead Sciences worth $364K as of Q3 2021.
  • NorthCoast Asset Management bought 123 Gilead Sciences shares in Q3 2021, an estimated $8.64K.
  • Gilead Sciences made up 0.01% of NorthCoast Asset Management's portfolio in Q3 2021, its #372 holding.
  • NorthCoast Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 20 quarters since.
  • NorthCoast Asset Management's Gilead Sciences position peaked at $77.6M in Q1 2015.
  • 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.